Dublin, March 20, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/zrz6db/womens_health) has announced the addition of the "Women's Health - Assessing the Need for a Targeted and Specialized Approach" report to their offering.
The report provides an overview of issues and trends in Women's Health, including analysis of the current market landscape and key issues driving overall treatment decisions. In addition, the report offers a view of how Women's Health is likely to evolve, including treatment practices and new approaches in the pipeline.
Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge.
Women's Health is a collection of multi-factorial conditions and diseases that solely affect or are more prevalent in females. Many can have a serious impact on women's overall long-term health and quality of life. There are a number of causes of Women's Health diseases, ranging from hormonal fluctuations associated with specific points in a woman's life through to psychological issues underpinning certain lifestyle disorders. As these causes and the courses and consequences of these diseases become better understood, the importance of targeted, specific treatment is increasingly being recognized, with some female-specific interventions now being investigated. In addition, it is becoming increasingly crucial to understand and act on the interaction between different diseases that primarily affect women, in order to ensure the most effective treatment approaches.
Female cancers, particularly breast and cervical, have led the way in preventive and therapeutic approaches, creating new paths for the management of other cancers and rendering some previously highly terminal cancers manageable diseases. The advent of personalized therapy for HER2-positive breast cancer was enabled through the identification of the HER2 gene and development of targeted drugs, such as Herceptin (trastuzumab) and Tyverb (lapatinib), and the prevention of cancer through vaccination has become the norm for cervical cancer. However, the same cannot be said for other female cancers, where, in spite of identification of gene mutations, targeted therapy is still in its infancy.
Despite significant advances in Women's Health, there are still a number of unmet needs, particularly for therapies that address the fundamental causes of many conditions that are specific to or more prevalent in women. The fact that women are living longer means that they are encountering a wider range of health issues. It also means that there are higher expectations in therapies and that factors such as quality of life are playing an increasingly important role. As the Women's Health environment evolves and expectations in treatment increase, easier and more straightforward therapies will be needed, and there is a particular need for drugs that either address several aspects of Women's Health or work concomitantly with others to do so. Furthermore, it is recognized that many of the different conditions that affect women are interlinked and have common root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge. The specialists who can do this are likely to be the main points of care for Women's Health.
Key Topics Covered:
- Executive summary
- Methodology
- Women's Health: an overview
- Segment overviews
- Personalized medicine will herald a new era for hormonal conditions
- New innovations in reproductive medicine will continue to advance treatment
- The development of treatments for lifestyle conditions have stalled in recent years
- Several risk factors converge at specific points in a woman's life to increase the likelihood of suffering from serious health issues
- The future outlook
- Appendix
For more information visit http://www.researchandmarkets.com/research/zrz6db/womens_health